(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 7. Increased Hippo signaling, but not cell competition, controls apoptosis
in vps25 clones. (A-C) Caspase-3*-labeling of
vps25 mosaics (genotype: ey-FLP; FRT42D
vps25N55/FRT42D arm-lacZ M(2)) in a Minute
(M) background. Caspase-3* activity is unaffected. Clones
are marked by the absence of ß-Gal staining. (D-F)
Caspase-3*-labeling of GFP-marked vps25/dMyc mosaics
(hs-FLP UAS-GFP; FRT42 vps25N55/FRT42D tub-Gal80;
tub-Gal4/UAS-dMyc). Caspase-3*-activity is unaffected.
(G-I) Expanded (Ex) labeling of GFP-marked vps25 mosaics
(hs-FLP UAS-GFP; FRT42D vps25N55/FRT42D
tub-Gal80; tub-Gal4). Ex protein levels are reduced in
vps25 clones (arrow), indicating increased Hippo activity.
(J-L) Caspase-3*-labeling of GFP-marked vps25 hippo
double mutant mosaics (hs-FLP UAS-GFP; FRT42D vps25N55
hippo3D/FRT42D tub-Gal80; tub-Gal4).
Caspase-3* activity is blocked.